AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+7.83%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$2.5B
AUM Growth
-$1.57B
(-39%)
Cap. Flow
-$1.79B
Cap. Flow
% of AUM
-71.81%
Top 10 Holdings %
Top 10 Hldgs %
88.46%
Holding
621
New
174
Increased
68
Reduced
174
Closed
178
Top Buys
| 1 |
Citigroup
C
|
$175M |
| 2 |
Bank of America
BAC
|
$172M |
| 3 |
Wells Fargo
WFC
|
$171M |
| 4 |
JPMorgan Chase
JPM
|
$157M |
| 5 |
ICL Group
ICL
|
$132M |
Top Sells
| 1 |
Global X Copper Miners ETF NEW
COPX
|
$654M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
$450M |
| 3 |
Caterpillar
CAT
|
$422M |
| 4 |
Deere & Co
DE
|
$421M |
| 5 |
Home Depot
HD
|
$385M |
Sector Composition
| 1 | Financials | 42.44% |
| 2 | Materials | 18.49% |
| 3 | Technology | 15.23% |
| 4 | Industrials | 13.02% |
| 5 | Utilities | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$668B
| $160K | 0.01% |
19,645
-199
| -1% | -$1.62K |
|
102
Gilead Sciences
GILD
$140B
| $159K | 0.01% |
1,856
+121
| +7% | +$10.4K |
|
103
Oramed Pharmaceuticals
ORMP
$90.2M
| $153K | 0.01% |
+12,847
| New | +$153K |
|
104
PepsiCo
PEP
$201B
| $152K | 0.01% |
844
-204
| -19% | -$36.9K |
|
105
McDonald's
MCD
$227B
| $150K | 0.01% |
569
+345
| +154% | +$90.9K |
|
106
Vertex Pharmaceuticals
VRTX
$101B
| $148K | 0.01% |
513
-184
| -26% | -$53.1K |
|
107
Belden
BDC
$5.09B
| $140K | 0.01% |
+4,776
| New | +$140K |
|
108
Brenmiller Energy
BNRG
$6.63M
| $140K | 0.01% |
2,060
-5,740
| -74% | -$391K |
|
109
McKesson
MCK
$86.2B
| $125K | 0.01% |
334
-115
| -26% | -$43.1K |
|
110
Cardinal Health
CAH
$35.6B
| $123K | ﹤0.01% |
1,606
-576
| -26% | -$44.3K |
|
111
Pinterest
PINS
$25.2B
| $121K | ﹤0.01% |
4,981
+1,981
| +66% | +$48.1K |
|
112
Marathon Petroleum
MPC
$54.6B
| $117K | ﹤0.01% |
1,004
+960
| +2,182% | +$112K |
|
113
W.W. Grainger
GWW
$49B
| $116K | ﹤0.01% |
209
-85
| -29% | -$47.3K |
|
114
Opendoor
OPEN
$4.06B
| $116K | ﹤0.01% |
100,000
-964,884
| -91% | -$1.12M |
|
|
DNA.WS
115
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
| $116K | ﹤0.01% |
+578,845
| New | +$116K |
|
116
Valero Energy
VLO
$48.6B
| $116K | ﹤0.01% |
+911
| New | +$116K |
|
117
Carlyle Group
CG
$23.3B
| $113K | ﹤0.01% |
3,775
+442
| +13% | +$13.2K |
|
118
Johnson & Johnson
JNJ
$428B
| $112K | ﹤0.01% |
634
-84
| -12% | -$14.8K |
|
119
Viatris
VTRS
$12B
| $112K | ﹤0.01% |
+10,043
| New | +$112K |
|
120
Cleveland-Cliffs
CLF
$5.17B
| $111K | ﹤0.01% |
6,915
+1,408
| +26% | +$22.7K |
|
121
Ovintiv
OVV
$10.9B
| $111K | ﹤0.01% |
+2,189
| New | +$111K |
|
122
HF Sinclair
DINO
$9.68B
| $111K | ﹤0.01% |
+2,139
| New | +$111K |
|
123
Frontier Communications
FYBR
$9.3B
| $111K | ﹤0.01% |
+4,339
| New | +$111K |
|
124
Diamondback Energy
FANG
$41.4B
| $110K | ﹤0.01% |
+802
| New | +$110K |
|
125
Builders FirstSource
BLDR
$15.6B
| $108K | ﹤0.01% |
1,672
-274
| -14% | -$17.8K |
|